ReviewHeart failure reviews2020
Heart failure in adult congenital heart disease: tetralogy of Fallot.
Review in Heart failure reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 29 citations in OpenAlex.
- Development and Validation of a Predictive Screening Model for Congenital Heart Disease in High-Altitude Children.Risk management and healthcare policy · 2026Article
- Global, regional, and national burden of heart failure and its risk factors between 1990 and 2021 and projections to 2050: an analysis of the global burden of disease study.European heart journal. Quality of care & clinical outcomes · 2025Article
- Right ventricular dysfunction following tetralogy of Fallot correction: anatomical determinants and therapeutic strategies.International journal of surgery (London, England) · 2025Review
- Atrioventricular Area Difference Aids Diastolic Filling in Patients with Repaired Tetralogy of Fallot.Pediatric cardiology · 2025Article
- Concurrent Acute Limb Ischemia and Pulmonary Embolism in an Adult With Repaired Tetralogy of Fallot: A Case Report.Cureus · 2025Article
- Early postoperative tachyarrhythmias in adult congenital heart surgery: an eight-year review at a tertiary university hospital in Thailand.Journal of thoracic disease · 2024Article
- BLN protein induces cardiac hypertrophy and failure.Nature cardiovascular research · 2023Article
- Staged definitive repair for pulmonary atresia and ventricular septal defect 40 years after palliative surgery: a case report.General thoracic and cardiovascular surgery cases · 2023Article
- Clinical profile of congenital heart diseases detected in a tertiary hospital in China: a retrospective analysis.Frontiers in cardiovascular medicine · 2023Article
- BBLN triggers CAMK2D pathology in mice under cardiac pressure overload and potentially in unrepaired hearts with tetralogy of Fallot.Nature cardiovascular research · 2023Article
- Albuminuria and Renal Pathology in Right Heart Failure: Congestive Kidney?Kidney international reports · 2022Article
- Increasing age and atrial arrhythmias are associated with increased thromboembolic events in a young cohort of adults with repaired tetralogy of Fallot.Journal of arrhythmia · 2021Article
- The Interplay between Myocardial Fibrosis, Strain Imaging and Collagen Biomarkers in Adults with Repaired Tetralogy of Fallot.Diagnostics (Basel, Switzerland) · 2021Article
- Perioperative care of adults with Down syndrome: a narrative review.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2021Review
- Antenatal and Perioperative Mechanisms of Global Neurological Injury in Congenital Heart Disease.Pediatric cardiology · 2021Review
- The success and failure of the adult congenital heart.Heart failure reviews · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The number of rTOF patients who survive into adulthood is steadily rising, with currently more than 90% reaching the third decade of life. However, rTOF patients are not cured, but rather have a lifelong increased risk for cardiac and non-cardiac complications. Heart failure is recognized as a significant complication. Its occurrence is strongly associated with adverse outcome. Unfortunately, conventional concepts of heart failure may not be directly applicable in this patient group. This article presents a review of the current knowledge on HF in rTOF patients, including incidence and prevalence, the most common mechanisms of heart failure, i.e., valvular pathologies, shunt lesions, left atrial hypertension, primary left heart and right heart failure, arrhythmias, and coronary artery disease. In addition, we will review information regarding extracardiac complications, risk factors for the development of heart failure, clinical impact and prognosis, and assessment possibilities, particularly of the right ventricle, as well as management strategies. We explore potential future concepts that may stimulate further research into this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.